Wenying Yu, Ph.D.
Affiliations: | 2013 | Pharmacy | Ohio State University, Columbus, Columbus, OH |
Area:
PharmacologyGoogle:
"Wenying Yu"Bio:
http://rave.ohiolink.edu/etdc/view?acc_num=osu1373328058
Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Chenglong Li | grad student | 2013 | Ohio State (Chemistry Tree) | |
| (Computational, Synthetic, Biochemical and Biological Studies and Characterization on STAT3 Inhibitors for Potential Anticancer Therapy.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Liu Z, Ma L, Sun Y, et al. (2021) Targeting STAT3 signaling overcomes gefitinib resistance in non-small cell lung cancer. Cell Death & Disease. 12: 561 |
| Ren Y, Li S, Zhu R, et al. (2021) Discovery of STAT3 and Histone Deacetylase (HDAC) Dual-Pathway Inhibitors for the Treatment of Solid Cancer. Journal of Medicinal Chemistry |
| Chen RL, Wang Z, Huang P, et al. (2021) Isovitexin potentiated the antitumor activity of cisplatin by inhibiting the glucose metabolism of lung cancer cells and reduced cisplatin-induced immunotoxicity in mice. International Immunopharmacology. 107357 |
| Song D, Yu W, Ren Y, et al. (2020) Discovery of bazedoxifene analogues targeting glycoprotein 130. European Journal of Medicinal Chemistry. 199: 112375 |
| Xu G, Zhang Y, Wang H, et al. (2020) Synthesis and biological evaluation of 4-(pyridin-4-oxy)-3-(3,3-difluorocyclobutyl)-pyrazole derivatives as novel potent transforming growth factor-β type 1 receptor inhibitors. European Journal of Medicinal Chemistry. 198: 112354 |
| Pan L, Chen X, Fu S, et al. (2020) LLY17, a novel small molecule STAT3 inhibitor induces apoptosis and suppresses cell migration and tumor growth in triple-negative breast cancer. Breast Cancer Research and Treatment |
| Wang H, Liu Z, Guan L, et al. (2020) LYW-6, a Novel Cryptotanshinone Derived STAT3 Targeting Inhibitor, Suppresses Colorectal Cancer Growth and Metastasis. Pharmacological Research. 104661 |
| Zhu J, Chen J, Song D, et al. (2019) Real-time monitoring of etoposide prodrug activated by hydrogen peroxide with improved safety. Journal of Materials Chemistry. B |
| Liu Z, Wang H, Guan L, et al. (2019) LL1, a novel specific STAT3 inhibitor, displays anti-colorectal cancer activities in vitro and in vivo. British Journal of Pharmacology |
| Li Y, Wang Y, Shi Z, et al. (2019) Clinicopathological and Prognostic Role of STAT3/p-STAT3 in Breast Cancer Patients in China: A Meta-Analysis. Scientific Reports. 9: 11243 |